- ‘Shots-on-Goal’ business model
- 2013 and 2014 financial guidance
- Detailed overview of tax assets
- Impact of recent FDA approvals for partnered programs
- Update on key pipeline assets
- Summary of upcoming events
Trade-Ideas LLC identified Ligand Pharmaceuticals (LGND) as a weak on high relative volume candidate
Here are Friday's top research calls, including downgrades for FireEye and Teva Pharmaceuticals, and upgrades for Kraft Heinz and U.S. Steel.
Trade-Ideas LLC identified Ligand Pharmaceuticals (LGND) as a "perilous reversal" (up big yesterday but down big today) candidate
Shares of SAGE Therapeutics jumped after the company reported data from its SAGE-547 clinical trial for the treatment of severe postpartum depression.